Status:
RECRUITING
Exploratory Study on HER2 Detection Method and Positive Threshold for High-grade Serous Adenocarcinoma of the Ovary
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions:
Exploring HER2 Positive Diagnostic Criteria in High-grade Serous Ovarian Cancer
Observing the Effectiveness of Targeted HER2 ADC Drugs
Eligibility:
FEMALE
18-75 years
Brief Summary
Ovarian cancer is the most lethal gynecological malignancy, and 70% of ovarian cancer patients are diagnosed late at the time of new diagnosis. Even after systematic treatment, 75% of patients still r...
Eligibility Criteria
Inclusion
- Pathological type: high-grade serous adenocarcinoma of the ovary
- Pathological slices stored within 5 years
- FIGO stage II or above
- Complete clinical and follow-up data
Exclusion
- Slice quality control failure
- Incomplete follow-up data
Key Trial Info
Start Date :
April 7 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2027
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06883487
Start Date
April 7 2024
End Date
March 31 2027
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, China